Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15–26 Years of Age
Suzanne M. Garland, Elmar A. Joura, Kevin A. Ault, et al.
Obstetrics and Gynecology (2018) Vol. 132, Iss. 2, pp. 261-270
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma
Nikki B. Thuijs, Marc van Beurden, Annette H. Bruggink, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 1, pp. 90-98
Open Access | Times Cited: 75
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions
Mario Preti, Elmar A. Joura, Pedro Vieira‐Baptista, et al.
Journal of Lower Genital Tract Disease (2022)
Open Access | Times Cited: 39
Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis
Zhuang Li, Penglin Liu, Ziying Wang, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 4, pp. 403-414
Closed Access | Times Cited: 30
Topical imiquimod versus surgery for vulvar intraepithelial neoplasia: a multicentre, randomised, phase 3, non-inferiority trial
Gerda Trutnovsky, Olaf Reich, Elmar A. Joura, et al.
The Lancet (2022) Vol. 399, Iss. 10337, pp. 1790-1798
Closed Access | Times Cited: 32
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions
Mario Preti, Elmar A. Joura, Pedro Vieira‐Baptista, et al.
International Journal of Gynecological Cancer (2022) Vol. 32, Iss. 7, pp. 830-845
Open Access | Times Cited: 31
Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer
Lukai Zhai, Rashi Yadav, Nitesh K. Kunda, et al.
Antiviral Research (2019) Vol. 166, pp. 56-65
Open Access | Times Cited: 53
Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy
Elmar A. Joura, Maria Kyrgiou, Francisco Xavier Bosch, et al.
European Journal of Cancer (2019) Vol. 116, pp. 21-26
Open Access | Times Cited: 47
Clinical and molecular classification of vulvar squamous pre-cancers
Paul A. Cohen, Lyndal Anderson, Lois Eva, et al.
International Journal of Gynecological Cancer (2019) Vol. 29, Iss. 4, pp. 821-828
Closed Access | Times Cited: 46
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study
Elmar A. Joura, Àngels Ulied, Corinne Vandermeulen, et al.
Vaccine (2021) Vol. 39, Iss. 20, pp. 2800-2809
Open Access | Times Cited: 33
Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease
Alessandro Ghelardi, R Marrai, Giorgio Bogani, et al.
Vaccines (2021) Vol. 9, Iss. 2, pp. 83-83
Open Access | Times Cited: 32
Squamous Cell Carcinoma In Situ—The Importance of Early Diagnosis in Bowen Disease, Vulvar Intraepithelial Neoplasia, Penile Intraepithelial Neoplasia, and Erythroplasia of Queyrat
Lucian G. Scurtu, Francesca Scurtu, Sebastian Catalin Dumitrescu, et al.
Diagnostics (2024) Vol. 14, Iss. 16, pp. 1799-1799
Open Access | Times Cited: 4
Adjuvant nonavalent HPV vaccination in women treated for vulvar HSIL, a randomized placebo-controlled trial; VulVaccin study protocol
Vera J G M Vaessen, Ralf L O van de Laar, Marta Piso-Jozwiak, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
The Changing Spectrum of Sexually Transmitted Infections in Europe
Angelika Stary
Acta Dermato Venereologica (2020) Vol. 100, Iss. 9, pp. adv00114-247
Open Access | Times Cited: 22
Vulval premalignant lesions: a review article
Sumedha Gupta, Sana Ahuja, Dheer Singh Kalwaniya, et al.
Obstetrics & Gynecology Science (2024) Vol. 67, Iss. 2, pp. 169-185
Open Access | Times Cited: 1
Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51
Rashi Yadav, Lukai Zhai, Nitesh K. Kunda, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1113-1113
Open Access | Times Cited: 9
Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard
Alyssa M. Cornall, Julia Brotherton, Emma T. Callegari, et al.
Vaccine (2020) Vol. 38, Iss. 40, pp. 6312-6319
Closed Access | Times Cited: 6
Prevalence and type distribution of human papillomavirus infections in Danish patients diagnosed with vulvar squamous cell tumors and precursors
Annemarie Brusen Villadsen, Caspar Bundgaard‐Nielsen, Lea Maria Margareta Ambühl, et al.
Gynecologic Oncology Reports (2021) Vol. 37, pp. 100828-100828
Open Access | Times Cited: 5
A Few More Reasons to Vaccinate Against Human Papillomavirus
Sarah Feldman
Obstetrics and Gynecology (2018) Vol. 132, Iss. 2, pp. 259-260
Closed Access | Times Cited: 3
Virus Papiloma Humano. Un enemigo silencioso en el Ecuador y el mundo
Julia Irma Carrión Ordóñez, Sara Elizabeth Bravo Salinas, Fabian Alejandro Escandón Carrión, et al.
(2024)
Open Access
Human Papillomaviruses: Benign and Malignant Disease
Suzanne M. Garland, Anna‐Lise Williamson, Julia Brotherton
Springer eBooks (2024), pp. 1-48
Closed Access
Human Papillomaviruses: Benign and Malignant Disease
Suzanne M. Garland, Anna‐Lise Williamson, Julia Brotherton
Springer eBooks (2024), pp. 1-48
Closed Access
High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia
Chao Zhao, Jiahui An, Mingzhu Li, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2107-2107
Open Access
Clinical Trials of Human Papillomavirus Vaccines
Jorma Paavonen, Suzanne M. Garland, David Jenkins
Elsevier eBooks (2019), pp. 299-325
Closed Access | Times Cited: 2
Vulvar, Penile, and Scrotal Human Papillomavirus and Non–Human Papillomavirus Cancer Pathways
Elmar A. Joura, David Jenkins, Núria Guimerà
Elsevier eBooks (2019), pp. 219-230
Closed Access | Times Cited: 1
Does Human Papillomavirus Infection Influence the Frequency and Severity of Nutritional Disorders in Head and Neck Cancer?
Marcin Mazurek, Radosław Mlak, Agata Kot-Waśik, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4528-4528
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top